🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sabine Eckhardt

Chr. Michelsen Institute

ORCID: 0000-0001-6958-5375

Also affiliated with Kjeller Innovasjon (Norway), Institute of Atmospheric Sciences and Climate, NILU

Earth and Planetary SciencesEnvironmental ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Three-Dimensional Regeneration of Patient-Derived Intestinal Organoid Epithelium in a Physiodynamic Mucosal Interface-on-a-Chip”.

Three-Dimensional Regeneration of Patient-Derived Intestinal Organoid Epithelium in a Physiodynamic Mucosal Interface-on-a-Chip

Micromachines(2020)10.3390/mi11070663
N/A
0DataRank · unranked
88 citations

Woojung Shin, Domin Koh, Alexander Wu, Yoko M. Ambrosini, So‐Youn Min +8 more

Spatiotemporal Gradient and Instability of Wnt Induce Heterogeneous Growth and Differentiation of Human Intestinal Organoids

iScience(2020)10.1016/j.isci.2020.101372
N/A
0DataRank · unranked
79 citations

Alexander Wu, So‐Youn Min, Yong Cheol Shin, Rachel Fleming, Sabine Eckhardt +2 more

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12030719
N/A
0DataRank · unranked
24 citations

Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman +7 more

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2021.642328
N/A
0DataRank · unranked
30 citations

Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu +8 more

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Cancers(2023)10.3390/cancers16010091
N/A
0DataRank · unranked
11 citations

Jodi Kagihara, Bradley R. Corr, S. Lindsey Davis, Christopher H. Lieu, Sunnie S. Kim +14 more